Henry Loret de Mola possesses extensive experience in market access roles within the pharmaceutical and biotechnology sectors. Currently serving as Head of Market Access at ImmunityBio, Inc., Henry has previously held titles such as National Account Lead at VBI Vaccines Inc. and Syneos Health, as well as National Account Manager positions focused on Market Access at Acerus Pharma and CeQur, and a Specialty National Account Manager role at GSK - US Vaccines. Henry earned a Bachelor of Science degree in Biomedical Engineering from Marquette University between 1981 and 1985.